Molecular Mechanism of Salvia Miltiorrhiza in the Treatment of Colorectal Cancer Based on Network Pharmacology and Molecular Docking Technology [Corrigendum]

Jiang YL, Xun Y. Drug Des Devel Ther. 2024;18:425—441. It has been advised that there is an error in Figure 11A on page 439 of the published article. This error was a result of an incorrect image being uploaded during the submission process. The correct Figure 11 which accurately represents the results as described in the manuscript is shown below. Figure 11 Effects of Salvia miltiorrhiza on the apoptosis of human HCT116 colorectal cancer cells and core targets. HCT116 colorectal cancer cells were treated with Salvia miltiorrhiza at 5 μg/mL, 10 μg/mL and 20 μg/mL, or 5-Fu at 20 μM, followed by the analyses of TUNEL and qRT-PCR. (A and B) TUNEL analysis of the apoptosis of HCT116 cells treated with Salvia miltiorrhiza or 5-Fu. Original magnification: 10×. (C and D) The real-time qRT-PCR analysis of the mRNA levels of Bax and Bcl-2 in HCT116 cells treated with Salvia miltiorrhiza or 5-Fu. (E and F). The real-time qRT-PCR analysis of the mRNA levels of caspase-9 and caspase-3 in HCT116 cells treated with Salvia miltiorrhiza or 5-Fu. (G–I) The real-time qRT-PCR analysis of the mRNA levels of SRC, IL-6, and INS in HCT116 cells treated with Salvia miltiorrhiza or 5-Fu. Scale bar: 50 μm. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs Control.Abbreviation: ns, not significant. This correction does not affect the results or conclusions of the article. The authors apologize for this oversight and appreciate the opportunity to correct the error.